Trial Profile
Efficacy of recombinant human endostatin combined with TACE on hepatocellular carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2017
Price :
$35
*
At a glance
- Drugs Endostatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Feb 2017 New trial record